139 related articles for article (PubMed ID: 8938517)
21. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
Reems JA; Mielcarek M; Torok-Storb B
Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
[TBL] [Abstract][Full Text] [Related]
22. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
[TBL] [Abstract][Full Text] [Related]
23. The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood.
Shapiro F; Pytowski B; Rafii S; Witte L; Hicklin DJ; Yao TJ; Moore MA
J Hematother; 1996 Dec; 5(6):655-62. PubMed ID: 9117254
[TBL] [Abstract][Full Text] [Related]
24. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
25. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
26. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
LaIuppa JA; Papoutsakis ET; Miller WM
Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
28. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system.
Koller MR; Manchel I; Maher RJ; Goltry KL; Armstrong RD; Smith AK
Bone Marrow Transplant; 1998 Apr; 21(7):653-63. PubMed ID: 9578304
[TBL] [Abstract][Full Text] [Related]
29. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit.
Jin L; Neff T; Blau CA
Exp Hematol; 1999 Mar; 27(3):520-5. PubMed ID: 10089915
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination.
Robinson S; Mosley RL; Parajuli P; Pisarev V; Sublet J; Ulrich A; Talmadge J
J Hematother Stem Cell Res; 2000 Oct; 9(5):711-20. PubMed ID: 11091495
[TBL] [Abstract][Full Text] [Related]
31. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
[TBL] [Abstract][Full Text] [Related]
32. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
33. Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein.
Sonoda Y; Kimura T; Sakabe H; Tanimukai S; Ohmizono Y; Nakagawa S; Yokota S; Lyman SD; Abe T
Eur J Haematol; 1997 Apr; 58(4):257-64. PubMed ID: 9186537
[TBL] [Abstract][Full Text] [Related]
34. Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct.
Gotze KS; Ramirez M; Tabor K; Small D; Matthews W; Civin CI
Blood; 1998 Mar; 91(6):1947-58. PubMed ID: 9490677
[TBL] [Abstract][Full Text] [Related]
35. Replating potential of colony-forming units of granulocytes/macrophages (CFU-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin.
Katayama Y; Takenaka K; Mahmut N; Teshima T; Shinagawa K; Omoto E; Harada M
Int J Hematol; 1998 Aug; 68(2):157-68. PubMed ID: 9803674
[TBL] [Abstract][Full Text] [Related]
36. Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
Strife A; Wisniewski D; Liu C; Lambek CL; Darzynkiewicz Z; Silver RT; Clarkson B
Mol Cancer Res; 2003 Jan; 1(3):176-85. PubMed ID: 12556557
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
[TBL] [Abstract][Full Text] [Related]
38. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.
Yu H; Fehniger TA; Fuchshuber P; Thiel KS; Vivier E; Carson WE; Caligiuri MA
Blood; 1998 Nov; 92(10):3647-57. PubMed ID: 9808558
[TBL] [Abstract][Full Text] [Related]
39. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells.
McKenna HJ; de Vries P; Brasel K; Lyman SD; Williams DE
Blood; 1995 Nov; 86(9):3413-20. PubMed ID: 7579445
[TBL] [Abstract][Full Text] [Related]
40. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.
Hudak S; Hunte B; Culpepper J; Menon S; Hannum C; Thompson-Snipes L; Rennick D
Blood; 1995 May; 85(10):2747-55. PubMed ID: 7537980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
